These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23400670)

  • 1. Shortened telomere length in patients with systemic lupus erythematosus.
    Haque S; Rakieh C; Marriage F; Ho P; Gorodkin R; Teh LS; Snowden N; Day PJ; Bruce IN
    Arthritis Rheum; 2013 May; 65(5):1319-23. PubMed ID: 23400670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between shortened telomere length and systemic lupus erythematosus: a meta-analysis.
    Lee YH; Jung JH; Seo YH; Kim JH; Choi SJ; Ji JD; Song GG
    Lupus; 2017 Mar; 26(3):282-288. PubMed ID: 27510600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of carotid atherosclerosis in systemic lupus erythematosus.
    Maksimowicz-McKinnon K; Magder LS; Petri M
    J Rheumatol; 2006 Dec; 33(12):2458-63. PubMed ID: 17014002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Premature telomere shortening in polymorphonuclear neutrophils from patients with systemic lupus erythematosus is related to the lupus disease activity.
    Wu CH; Hsieh SC; Li KJ; Lu MC; Yu CL
    Lupus; 2007; 16(4):265-72. PubMed ID: 17439933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
    J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomere length in patients with systemic lupus erythematosus and its associations with carotid plaque.
    Skamra C; Romero-Diaz J; Sandhu A; Huang Q; Lee J; Pearce W; McPherson DD; Sutton-Tyrrell K; Pope R; Ramsey-Goldman R
    Rheumatology (Oxford); 2013 Jun; 52(6):1101-8. PubMed ID: 23382361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal telomerase activity and telomere length in T and B cells from patients with systemic lupus erythematosus.
    Kurosaka D; Yasuda J; Yoshida K; Yoneda A; Yasuda C; Kingetsu I; Toyokawa Y; Yokoyama T; Saito S; Yamada A
    J Rheumatol; 2006 Jun; 33(6):1102-7. PubMed ID: 16755657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nighttime Blood Pressure Patterns and Subclinical Atherosclerosis in Women with Systemic Lupus Erythematosus.
    Sabio JM; Martinez-Bordonado J; Sánchez-Berná I; Vargas-Hitos JA; Mediavilla JD; Navarrete-Navarrete N; Zamora-Pasadas M; Ruíz ME; Jiménez-Alonso J
    J Rheumatol; 2015 Dec; 42(12):2310-7. PubMed ID: 26568596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Risk factors of thickened intima-media and atherosclerotic plaque development in carotid arteries in patients with systemic lupus erythematosus].
    Fischer K
    Ann Acad Med Stetin; 2008; 54(2):22-32. PubMed ID: 19374227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Telomere length analysis in monocytes and lymphocytes from patients with systemic lupus erythematosus using multi-color flow-FISH.
    Beier F; Balabanov S; Amberger CC; Hartmann U; Manger K; Dietz K; Kötter I; Brummendorf TH
    Lupus; 2007; 16(12):955-62. PubMed ID: 18042589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study.
    Bessant R; Duncan R; Ambler G; Swanton J; Isenberg DA; Gordon C; Rahman A
    Arthritis Rheum; 2006 Dec; 55(6):892-9. PubMed ID: 17139666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
    Ahmad Y; Shelmerdine J; Bodill H; Lunt M; Pattrick MG; Teh LS; Bernstein RM; Walker MG; Bruce IN
    Rheumatology (Oxford); 2007 Jun; 46(6):983-8. PubMed ID: 17384179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
    Salmon JE; Roman MJ
    Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Telomere shortening and decreased replicative potential, contrasted by continued proliferation of telomerase-positive CD8+CD28(lo) T cells in patients with systemic lupus erythematosus.
    Honda M; Mengesha E; Albano S; Nichols WS; Wallace DJ; Metzger A; Klinenberg JR; Linker-Israeli M
    Clin Immunol; 2001 May; 99(2):211-221. PubMed ID: 11318593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic lupus erythematosus and vitamin D deficiency are associated with shorter telomere length among African Americans: a case-control study.
    Hoffecker BM; Raffield LM; Kamen DL; Nowling TK
    PLoS One; 2013; 8(5):e63725. PubMed ID: 23700431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study.
    Ajeganova S; Gustafsson T; Jogestrand T; Frostegård J; Hafström I
    Arthritis Res Ther; 2015 Mar; 17(1):84. PubMed ID: 25885788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
    Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
    Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome, endothelial injury, and subclinical atherosclerosis in patients with systemic lupus erythematosus.
    Mok CC; Poon WL; Lai JP; Wong CK; Chiu SM; Wong CK; Lun SW; Ko GT; Lam CW; Lam CS
    Scand J Rheumatol; 2010; 39(1):42-9. PubMed ID: 20132070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
    Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
    Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating endothelial cells as a marker of vascular dysfunction in patients with systemic lupus erythematosus by real-time polymerase chain reaction.
    Attia FM; Maaty A; Kalil FA
    Arch Pathol Lab Med; 2011 Nov; 135(11):1482-5. PubMed ID: 22032577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.